mycoplasma
Roche Gets 510(k) Clearance, CLIA Waiver for Liat Triplex Point-of-Care STI Test
The point-of-care assay to detect and differentiate chlamydia, gonorrhea, and mycoplasma infections from a single sample will now be commercially available in the US in coming months.
Roche, SpeeDx Partner to Expand Access to Antibiotic Resistance Tests
Roche will have non-exclusive access to SpeeDx's existing tests and technology to enable expansion of diagnostic products for antibiotic resistance in STIs.
NeuMoDx T. Vaginalis, M. Genitalium Assay CE Marked
The molecular assay detects and differentiates Trichomonas vaginalis and/or Mycoplasma genitalium in clinical urine samples.
As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow
Premium
New resistance tests for Mycoplasma genitalium and gonorrhea could help stave off superbugs, but guidelines and economic factors may hinder adoption.
SpeeDx Gets Health Canada Approval for Mycoplasma Genitalium ID, Drug Resistance Test
The test could potentially enable labs to bring resistance testing in house, rather than send testing out to Canada's National Microbiology Laboratory.